0001012975-15-000431.txt : 20150601 0001012975-15-000431.hdr.sgml : 20150601 20150601163134 ACCESSION NUMBER: 0001012975-15-000431 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150528 FILED AS OF DATE: 20150601 DATE AS OF CHANGE: 20150601 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sage Therapeutics, Inc. CENTRAL INDEX KEY: 0001597553 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-299-8380 MAIL ADDRESS: STREET 1: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NELSEN ROBERT CENTRAL INDEX KEY: 0001219042 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36544 FILM NUMBER: 15903792 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2015-05-28 0001597553 Sage Therapeutics, Inc. SAGE 0001219042 NELSEN ROBERT 8725 WEST HIGGINS ROAD SUITE 290 CHICAGO IL 60631 1 0 1 0 Stock Option (right to buy) 73.13 2015-05-28 4 A 0 13922 73.13 A 2025-05-28 Common Stock 13922 13922 D The stock option award was issued pursuant to the Sage Therapeutics, Inc., 2014 Stock Option and Incentive Plan. The option shall vest in full on May 28, 2016, subject to continued service through such date. /s/ Robert Nelsen 2015-05-29